Why CFU Isn't the Whole Story (How to Read a Women's Probiotic Label)

Every women's probiotic on the UK market sells on the same number: CFU count. "50 billion live cultures." "10 billion CFU." "25 billion guaranteed." It's the headline figure on the front of the box, and it's almost entirely the wrong thing to compare.

CFU — Colony-Forming Units — is a count of how many live bacterial cells a capsule or sachet contains. It tells you the supplement has a lot of bacteria. It doesn't tell you which bacteria, whether they're suited to where you want them to act, whether they survive long enough to do anything, or whether the brand has any clinical research behind the specific strains they've chosen. A 50-billion-CFU product made from the wrong species is still the wrong product.

This article is about what to look at instead. Same framework we use when we formulate Femme Flora: composition over count, named species over blends, prebiotic support over CFU theatre.

What does CFU actually mean (and why it's not enough)?

CFU stands for Colony-Forming Units. It's a microbiology measurement: the number of live bacterial cells in a sample capable of forming a visible colony when cultured under standard lab conditions. On a supplement label, CFU is the count of viable bacteria the manufacturer guarantees at a stated point in time — usually either at manufacture or at end of expiry.

The CFU number has two real problems as a buying signal.

The first is the manufacture-vs-expiry question. Many probiotic labels disclose CFU "at time of manufacture" — meaning the actual viable count at the moment you swallow the capsule is lower, sometimes much lower. Bacteria die during storage. Heat, humidity, and time all reduce viable count. A "25 billion CFU" capsule labelled at manufacture might deliver 5–10 billion by the time you take it. A more transparent label states CFU "at end of expiry" or "guaranteed until expiry" — meaning the number on the box is what arrives in your gut.

The second is the species composition question. CFU counts total live cells, not whether those cells are the right cells for what you're trying to support. 50 billion CFU of a generic gut-bacterial blend is not the same supplement as 50 billion CFU of a women's-specific composition that includes vaginal-native species. The total looks identical. The biology is not.

The same trap we covered in our piece on what "clinical dose" actually means applies here. The headline number on the label borrows credibility from research, but the formulation underneath determines whether the research applies.

The three things that matter more than CFU count

If CFU isn't the right comparison, what is? Three things — in this order.

1. Are the species named individually? A label that lists "Probiotic Blend 10 billion CFU: Lactobacillus species" tells you nothing about what's actually in the capsule. A label that lists each species separately — Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus crispatus, and so on — is at least transparent. Proprietary blends in probiotics serve the same function as proprietary blends in any other supplement: they let the brand cut costs on the more expensive components without you knowing.

2. Does the composition include vaginal-native species? Most "women's probiotics" on UK shelves are gut probiotics with women's marketing. They contain species that thrive in the digestive tract — useful for gut health — but not the species that dominate healthy vaginal flora. Vaginal-native species (Lactobacillus crispatus, Lactobacillus gasseri, certain Lactobacillus rhamnosus strains) are different. Research suggests these species may colonise the vagina more reliably than gut-native species after oral administration. If the goal is supporting vaginal flora specifically, the species list matters more than the total count.

3. Is there prebiotic support? Probiotics are bacteria. Prebiotics are the fibres that feed bacteria. A probiotic without prebiotic support is sending bacteria into your gut without giving them anything to eat — which limits how well they survive and establish. The clinical research on long-term probiotic effect typically uses formulations with prebiotic support included. UK women's probiotics that skip prebiotics are leaving out half the supportive mechanism.

Three checks. None of them visible from the front of the box. All of them visible from the ingredient list on the back.

Why most "women's probiotics" are actually gut probiotics

This is the part of the women's probiotic category that the marketing doesn't say out loud: most products positioned as "women's probiotics" contain the same species as the general-purpose gut probiotics sitting on the next shelf. The packaging is different. The composition often isn't.

The vaginal microbiome is genuinely different from the gut microbiome. A 2003 randomised placebo-controlled trial by Reid and colleagues first demonstrated that specific Lactobacillus strains — L. rhamnosus GR-1 and L. reuteri RC-14 — could reach and colonise the vaginal tract after oral administration. Subsequent research has extended this picture: oral probiotics influence vaginal flora through at least three pathways, including direct bacterial migration via the perineum, an IgA-mediated immune signalling axis between the gut and vaginal mucosa, and the estrobolome pathway where gut bacteria affect circulating oestrogen levels that feed vaginal Lactobacillus populations.

The implication is straightforward. Not all probiotic species are equally suited to influencing vaginal flora. The species that occur naturally in healthy vaginal tissue — particularly Lactobacillus crispatus, which dominates the most stable vaginal microbiome states — are the species best positioned to support what they evolved to do. A "women's probiotic" that contains only generic Lactobacillus acidophilus and Bifidobacterium species (both gut-native) is fundamentally a gut formulation with a pink label.

The single most useful question to ask of any women's probiotic is: does this formulation contain species that occur naturally in healthy vaginal flora? The answer is on the ingredient list. L. crispatus on the label is the strongest single signal that the brand has formulated for the vaginal microbiome, not just labelled for it.

The UK regulatory blind spot — why every probiotic claim sits in a grey area

Here's a fact that almost no UK probiotic marketing makes visible: the European Food Safety Authority has not authorised any specific health claims for probiotics. Not one. The GB Nutrition and Health Claims Register — which is the UK's post-Brexit successor to the EU framework — contains zero authorised health claims for any probiotic species or strain.

This has a practical regulatory consequence. UK supplement brands cannot legally use the word "probiotic" in a context that implies a health benefit. That's why you'll often see UK labels use phrases like "live cultures," "live bacteria," "friendly bacteria," or "bio-cultures" instead. The ingredient is permitted; the implied health claim attached to the word "probiotic" is not.

Several layers of UK authority intersect here. The Food Standards Agency regulates probiotics as foods (not medicines). The Advertising Standards Authority polices what brands can claim about them. The Medicines and Healthcare products Regulatory Agency draws the line between food supplement and medicine. For more on how this framework operates across the supplement category, see our Compliance policy and the Health Claims References page where Evori publishes the authorised wording behind every ingredient claim we make.

What this means for buyers: every health-adjacent claim on a probiotic label exists in a regulatory grey area where the brand is implying something the regulator hasn't endorsed. Some brands stay carefully on the right side of the line (factual ingredient declarations, no functional claims). Some brands sail closer to the edge. None can point to an EFSA-authorised claim and say "this is regulator-approved." The framework above isn't pedantic — it's the only protection a UK buyer has against marketing claims regulators haven't blessed.

How UK women's probiotics compare

The simplest way to apply the framework is to lay UK women's probiotics out side by side and read what's on the label. Every figure below is taken from product pages or packaging as published.

Sources verified May 2026 from manufacturer product pages: Optibac For Women, Free Soul Intimate Flora, Bio-Kult Pro-Cyan, Symprove. Specifications taken from current product labels at time of publication. Manufacturers may reformulate; verify current labels before purchase.

Patterns emerge. The market splits broadly into two camps: high-CFU products with broader species lists (Femme Flora, Free Soul) and lower-CFU products with research-anchored strain identifiers (Optibac being the cleanest example). Optibac's "quality not quantity" positioning genuinely earns its premium: GR-1 and RC-14 have decades of clinical research specifically for women's intimate health, and L. paracasei F-19 is one of the better-researched additional strains. Bio-Kult also uses strain identifiers (their proprietary PXN designations), though their CFU count is the lowest of the products listed and L. helveticus and L. plantarum are gut-native species rather than vaginal-native ones.

The trade-offs are real. Higher diversity covers more of the vaginal microbiome's natural composition (16 species reflects how the body actually carries its flora). Lower-strain, higher-evidence formulations carry more research weight per species included. Strain identification matters more when the strains are the famously researched ones; proprietary strain codes without published research behind them are transparency without substance. There's no universal right answer — the framework just makes the trade-off visible. Most importantly: products that hide species behind "proprietary blends" or single-species "Lactobacillus" framing aren't competing on any dimension. They're trading on the CFU number alone.

Three questions to ask before buying a women's probiotic

If the framework feels like a lot to remember, distil it to three questions:

1. Are the species individually named on the label? If the answer is "Lactobacillus and Bifidobacterium blend," the brand isn't telling you what's in the bottle.
2. Does the composition include vaginal-native species — particularly Lactobacillus crispatus? If you're buying for vaginal flora support specifically, the species composition matters more than the total count.
3. Is there prebiotic support, or are you sending bacteria in unfed? Probiotic plus prebiotic is the formulation pattern the long-term research uses.

Three yeses doesn't guarantee a working product — there's no such guarantee in a category with zero authorised health claims. But three nos almost guarantees a product that's competing on marketing rather than substance.

One Last Thought

The CFU number on a probiotic label answers a question most buyers aren't actually asking. The questions that matter — what's in the formulation, whether the species suit the use case, whether the brand has anything to say beyond "billions" — are answered in the small print, not the big.

UK regulators have left this entire category in a grey area where no health claim is authorised and no minimum standard is set. The framework above isn't pedantic. It's the only protection a buyer has when the marketing layer says everything and the regulator says nothing.

Frequently Asked Questions

What does CFU mean on a probiotic label?

CFU stands for Colony-Forming Units — the count of live bacterial cells in a serving capable of forming a visible colony under standard lab conditions. It's a measure of total live bacteria, not which bacteria. A 50 billion CFU product made from the wrong species for your use case is still the wrong product. Composition matters more than count.

What's the difference between a gut probiotic and a vaginal probiotic?

The composition. Gut probiotics typically contain species that thrive in the digestive tract — useful for gut health. Vaginal-supportive probiotics include species that occur naturally in healthy vaginal flora, particularly Lactobacillus crispatus, Lactobacillus gasseri, and certain Lactobacillus rhamnosus strains. Research suggests these may colonise the vagina more reliably than gut-native species after oral administration.

How do probiotics taken orally reach the vagina?

Research has identified at least three pathways: direct bacterial migration via the perineum, an IgA-mediated immune signalling axis between the gut and vaginal mucosa, and the estrobolome pathway where gut bacteria affect circulating oestrogen levels that influence vaginal Lactobacillus populations. The species used matters — vaginal-native species appear to colonise more reliably than gut-native species.

Which probiotic strains have been researched for vaginal flora?

The most-researched strains for vaginal flora support are Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, established through trials beginning with Reid and colleagues in 2003. Lactobacillus crispatus has separate research showing it dominates the most stable vaginal microbiome states. Lactobacillus paracasei F-19 has more recent supporting evidence.

Is L. crispatus included in most women's probiotics?

No. Most UK women's probiotics contain Lactobacillus rhamnosus, Lactobacillus reuteri, or Lactobacillus acidophilus — but not L. crispatus, despite L. crispatus being the dominant species in the most stable vaginal microbiome states. Products that explicitly include L. crispatus are still rare in the UK category.

Does the UK regulate probiotic health claims?

Not at the level most buyers assume. The European Food Safety Authority has not authorised any specific health claims for probiotics, and the GB Nutrition and Health Claims Register contains zero authorised probiotic claims. UK brands cannot legally use the word "probiotic" in a context that implies a health benefit — which is why you'll see terms like "live cultures" or "bio-cultures" instead.

---